Edition:
United States

Koninklijke Philips NV (PHG.N)

PHG.N on New York Stock Exchange

41.74USD
22 Sep 2017
Change (% chg)

$-0.12 (-0.29%)
Prev Close
$41.86
Open
$41.95
Day's High
$42.01
Day's Low
$41.67
Volume
440,097
Avg. Vol
283,767
52-wk High
$42.09
52-wk Low
$28.19

Latest Key Developments (Source: Significant Developments)

Philips demonstrates efficacy of Stellarex .035" low-dose drug-coated balloon in clinical trial at two years
Thursday, 14 Sep 2017 03:34pm EDT 

Sept 14 (Reuters) - Koninklijke Philips Nv ::Efficacy of Philips' Stellarex .035" low-dose drug-coated balloon demonstrated in clinical trial at two years.Koninklijke Philips NV says ‍data shows Stellarex demonstrates higher efficacy and patency results, longer treatment durability compared to uncoated balloon​.Koninklijke Philips NV -‍ 2 year data from ILLUMENATE EURCT validates durable clinical performance of Stellarex low-dose drug-coated balloon​.  Full Article

Koninklijke Philips reclassified to health care sector by MSCI‍​
Monday, 4 Sep 2017 06:10am EDT 

Sept 4 (Reuters) - KONINKLIJKE PHILIPS NV ::PHILIPS RECLASSIFIED TO HEALTH CARE SECTOR BY MSCI‍​.RECLASSIFICATION EFFECTIVE AS OF OPENING OF EUROPEAN MARKETS ON SEPTEMBER 1, 2017.  Full Article

Koninklijke Philips prices offering of notes for 1.0 billion euros
Thursday, 31 Aug 2017 12:38pm EDT 

Aug 31 (Reuters) - KONINKLIJKE PHILIPS NV ::SUCCESSFULLY PRICES OFFERING OF NOTES FOR EUR 1.0 BILLION.ISSUE PRICE FOR FLOATING RATE NOTES IS 100.300% WITH A COUPON OF 3M EURIBOR + 20 BASIS POINTS.ISSUE PRICE FOR FIXED RATE NOTES IS 99.465% WITH A COUPON OF 0.500%, RESULTING IN A YIELD OF 0.591%.SETTLEMENT AND ISSUE OF NOTES IS SCHEDULED FOR SEPTEMBER 6, 2017.NET PROCEEDS OF OFFERING WILL BE USED FOR REPAYMENT OF EUR 1.0 BILLION BRIDGE LOAN.  Full Article

Philips and HeartFlow announce global collaboration agreement
Monday, 28 Aug 2017 04:00am EDT 

Aug 28 (Reuters) - KONINKLIJKE PHILIPS NV ::PHILIPS AND HEARTFLOW ANNOUNCE GLOBAL COLLABORATION AGREEMENT.  Full Article

Gigastorage files third trial appeal against Royal Philips of the Netherlands
Monday, 31 Jul 2017 04:33am EDT 

July 31 (Reuters) - Gigastorage Corp <2406.TW> ::* Says the company files a third trial appeal against Royal Philips of the Netherlands with Intellectual Property Court, on July 31, regarding DVD optical disk patent infringement case.* In the second trial, the company was ordered to pay T$1.05 billion to Royal Philips of the Netherlands.  Full Article

Philips Lighting Q2 net income rises to 73 million euros
Friday, 21 Jul 2017 01:14am EDT 

July 21 (Reuters) - PHILIPS LIGHTING NV ::H1 SALES AMOUNTED TO EUR 3,389 MILLION.REG-PHILIPS LIGHTING REPORTS SECOND QUARTER SALES OF EUR 1.7 BILLION AND OPERATIONAL PROFITABILITY OF 10.2%.Q2 ADJUSTED EBITA OF EUR 174 MILLION (Q2 2016: EUR 161 MILLION).Q2 NET INCOME OF EUR 73 MILLION (Q2 2016: EUR 57 MILLION).ON TRACK TO FURTHER IMPROVE ADJUSTED EBITA MARGIN BY 50-100 BASIS POINTS FOR FULL YEAR.ON TRACK TO DELIVER SOLID FREE CASH FLOW FOR FY.WHILE WE ARE CAUTIOUS GIVEN GLOBAL ECONOMIC UNCERTAINTY, WE ARE CONFIDENT THAT WE WILL RETURN TO POSITIVE COMPARABLE SALES GROWTH IN COURSE OF THIS YEAR.  Full Article

Koninklijke Philips signes an agreement to acquire TomTec Imaging Systems‍​
Tuesday, 18 Jul 2017 02:04am EDT 

July 18 (Reuters) - KONINKLIJKE PHILIPS NV ::SIGNED AN AGREEMENT TO ACQUIRE TOMTEC IMAGING SYSTEMS GMBH‍​.‍COMPLETION OF TRANSACTION IS EXPECTED LATER TODAY​.‍FINANCIAL DETAILS WERE NOT DISCLOSED​.  Full Article

Philips and West Physics sign partnership to provide healthcare organizations
Monday, 17 Jul 2017 11:45am EDT 

July 17 (Reuters) - KONINKLIJKE PHILIPS NV ::PHILIPS AND WEST PHYSICS SIGN EXCLUSIVE PARTNERSHIP TO PROVIDE HEALTHCARE ORGANIZATIONS WITH A COMPREHENSIVE RADIATION DOSE MANAGEMENT PROGRAM.  Full Article

Philips receives FDA clearance to market Bluecontrol
Thursday, 13 Jul 2017 09:00am EDT 

July 13 (Reuters) - KONINKLIJKE PHILIPS NV ::PHILIPS RECEIVES U.S. FDA 510(K) CLEARANCE TO MARKET ITS PHILIPS BLUECONTROL, A WEARABLE LIGHT THERAPY DEVICE TO TREAT MILD PSORIASIS AT HOME.‍IN U.S., BLUECONTROL IS A CLASS II PRESCRIPTION MEDICAL DEVICE DESIGNED FOR HOME USE.​.TO PREPARE FOR COMMERCIAL LAUNCH OF BLUECONTROL IN U.S. MARKET IN EARLY 2018..  Full Article

Koninklijke Philips and Singapore institute of advanced medicine sign agreement to open oncology center in Singapore
Thursday, 6 Jul 2017 04:12am EDT 

July 6 (Reuters) - KONINKLIJKE PHILIPS NV ::PHILIPS AND SINGAPORE INSTITUTE OF ADVANCED MEDICINE HOLDINGS SIGN AGREEMENT TO OPEN FIRST-OF-ITS-KIND ONCOLOGY CENTER IN SINGAPORE.SINGAPORE INSTITUTE OF ADVANCED MEDICINE HOLDINGS (SAM) IS INVESTING UP TO SGD 100 MILLION (ABOUT USD 72 MILLION).  Full Article

BRIEF-Koninklijke Philips reclassified to health care sector by MSCI‍​

* RECLASSIFICATION EFFECTIVE AS OF OPENING OF EUROPEAN MARKETS ON SEPTEMBER 1, 2017 Source text: http://philips.to/2gxBNPI Further company coverage: (Gdynia Newsroom:)